Identification of deletions and insertions in the p53 gene using multiplex PCR and high-resolution fragment analysis: Application to breast and ovarian tumors

Journal of Clinical Laboratory Analysis

Volumn 12, Issue 4, 1998, Pages 250-256

  Angelopoulou, Katerina ^a,b   Diamandis, Eleftherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; DNA sequencing; Fragment analysis; Gene deletions; Gene insertions; Ovarian cancer; p53 gene

Indexed keywords

PROTEIN P53;

ALLELE; ARTICLE; BASE PAIRING; BREAST TUMOR; DNA SEQUENCE; GENE DELETION; GENE DUPLICATION; GENE INSERTION; GENE THERAPY; HUMAN; HUMAN TISSUE; OVARY TUMOR; POINT MUTATION; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CLONING, MOLECULAR; DNA TRANSPOSABLE ELEMENTS; DNA, NEOPLASM; EXONS; FEMALE; GENES, P53; HUMANS; INTRONS; MUTATION; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION;

EID: 0031745713     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1998)12:4<250::AID-JCLA10>3.0.CO;2-U     Document Type: Article

References (26)

1. Lane, DP: p53, guardian of the genome. Nature 358. 15-16, 1992.
2. Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 70:523-526, 1992.
3. Marx, J: How p53 suppresses cell growth. Science 262:1644-1645, 1993.
4. El-Deiry WS, Tokino T, Velculescu VE, et al.: WAF1, a potential mediator of p53 tumor suppression. Cell 7:817-825, 1993.
5. Kastan MB, Zhan Q, El-Deiry WS, et al.: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia Cell 71:587-597, 1992.
6. Barak Y, Juven T, Haffner R, Oren M: Mdm-2 expression is induced by wild-type p53 activity. EMBO J 12:461-468, 1993.
7. Wales M, Biel MA, El-Deiry W, et al.: p53 activates expression of HIC-1. a new candidate tumor suppressor gene on 17p13.3. Nature Med 1:570-577, 1995.
8. Buckbinder L, Talbott R, Velasco-Miguel S, et al.: Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649, 1995.
9. Seto E, Usheva A, Zambetti GP, et al.: Wild-tpe p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci U S A 89:12028-12032, 1992.
10. Miyashita T, Harigai M, Hanada M, Reed JC: Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54:3131-3135, 1994.
11. Bakalkin G, Yakovleva T, Selivanova G, et al.: p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc Natl Acad Sci U S A 91:413-417, 1994.
12. Levine AJ, Momand J, Finlay, CA. The p53 tumor suppressor gene. Nature 351: 453-456, 1991.
13. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations m human cancers. Science 253:49-53, 1991.
14. Baker SJ, Pretsinger AC, Jessup JM, et al.: p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50:7717-7722, 1990.
15. Prosser J, Thompson AL, Cranston G, Evans HJ: Evidence that p53 behaves as a tumor suppressor gene in sporadic breast tumors Oncogene 5:1573-1579, 1990.
16. Takahashi T, Nau MM, Chiba I, et al.: p53-a frequent target for genetic abnormalities in lung cancer. Science 246:491-494, 1989.
17. Mazars R, Pujol P, Maudelonde T, Jeanteur P, Theillet C: p53 mutations in ovarian cancer-a late event. Oncogene 6:1685-1690, 1991.
18. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K: Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6:1313-1318, 1991.
19. Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies-association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991;88:5413-5417.
20. Miller CW, Aslo A, Tsay C, et al.: Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 50:7950-7954, 1990.
21. Jego N, Thomas G, Hamelin R: Short direct repeats flanking deletions and duplicating insertions in p53 gene in human cancers. Oncogene 8:209-213, 1993.
22. Runnebaum IB, Tong XW, Moebus V, Heilmann V, Keiback DG, Kreienberg R: Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines. Hum Genet 93:620-624, 1994.
23. Ausubel FM, et al.: Current Protocols in Molecular Biology. Vol 1, 2.2.1-2.2.2. John Wiley & Sons, Inc., 1995.
24. Hartmann A, Blaszyk H, McGovern RM, et al.: p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers. Oncogene 10:681-688, 1995.
25. Lazar V, Hazard F, Benin F, Janin N, Bellet D, Bressac B: Simple sequence repeat polymorphism within the p53 gene. Oncogene 8:1703-1705, 1993.
26. Hassapoglidou S, Diamandis EP, Sutherland DJA: Quantification of p53 protein in tumor cell lines, breast tissue extracts and serum with time-resolved immunofluorometry. Oncogene 8:1501-1509, 1993.